These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30141457)

  • 21. The association of ToRCH infection and congenital malformations: A prospective study in China.
    Wang Y; Li S; Ma N; Zhang Q; Wang H; Cui J; Wang S
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():336-340. PubMed ID: 31382146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of torch infection in bad obstetric history.
    Turbadkar D; Mathur M; Rele M
    Indian J Med Microbiol; 2003; 21(2):108-10. PubMed ID: 17642992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
    Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom.
    Abdel-Fattah SA; Bhat A; Illanes S; Bartha JL; Carrington D
    Prenat Diagn; 2005 Nov; 25(11):1028-31. PubMed ID: 16231309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for TORCH infections in pregnant women: a report from Delhi.
    Kaur R; Gupta N; Nair D; Kakkar M; Mathur MD
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of infectious agents in indigenous women of childbearing age in Venezuela].
    Monsalve-Castillo FM; Costa-León LA; Castellano ME; Suárez A; Atencio RJ
    Biomedica; 2012; 32(4):519-26. PubMed ID: 23715227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ELISA and TORCH complex: a comparison with the customary tests.
    Ferrucci M; Zavarini A
    Quad Sclavo Diagn; 1982 Sep; 18(3):258-67. PubMed ID: 6306715
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of Syrian refugees on congenital TORCH infections screening in Turkey.
    Çoşkun B; Gülümser Ç; Çoşkun B; Artuk C; Karaşahin KE
    J Obstet Gynaecol Res; 2020 Jul; 46(7):1017-1024. PubMed ID: 32343041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to use... neonatal TORCH testing.
    de Jong EP; Vossen AC; Walther FJ; Lopriore E
    Arch Dis Child Educ Pract Ed; 2013 Jun; 98(3):93-8. PubMed ID: 23470252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India.
    Prasoona KR; Srinadh B; Sunitha T; Sujatha M; Deepika ML; Vijaya Lakshmi B; Ramaiah A; Jyothy A
    J Obstet Gynaecol India; 2015 Oct; 65(5):301-9. PubMed ID: 26405399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.
    Stegmann BJ; Carey JC
    Curr Womens Health Rep; 2002 Aug; 2(4):253-8. PubMed ID: 12150751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing.
    Li Z; Yan C; Liu P; Yan R; Feng Z
    Clin Chim Acta; 2009 May; 403(1-2):212-5. PubMed ID: 19302994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases.
    Garland SM; Gilbert GL
    Med J Aust; 1993 Sep; 159(5):346-8. PubMed ID: 8395645
    [No Abstract]   [Full Text] [Related]  

  • 34. [Detection the serum IgM and IgG specific for TORCH in 1307 women in the period of pre-pregnancy and pregnancy].
    Qin W; Hu DC; Pang HL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):292-4. PubMed ID: 22097611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy.
    Palazzotto E; Bonura F; Calà C; Capra G; Pistoia D; Mangione D; Mascarella C; Minì G; Enea M; Giammanco GM; Ferraro D; De Grazia S
    J Med Microbiol; 2023 Jul; 72(7):. PubMed ID: 37458733
    [No Abstract]   [Full Text] [Related]  

  • 36. [Correlation between TORCH infections and abnormal pregnant outcomes].
    Zhang QQ; Cheng JZ; Wang FH
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):209-10. PubMed ID: 23894850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the relationship between the history of abnormal pregnancy and TORCH infection in pregnant woman].
    Cao Y; Qiu L; Zhang Q
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):517-20. PubMed ID: 11360633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [TORCH infections in mothers as a cause of neonatal morbidity].
    Mladina N; Mehikić G; Pasić A
    Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The obstetrician and TORCH infections today.
    Meloni A; Tuveri M; Cocco ME; Boi M; Portoghese E; Gariel D; Solinas AM; Melis E; Ferraguti P; Angioni G; Melis GB
    Pediatr Med Chir; 2005; 27(5):34-6. PubMed ID: 16913627
    [No Abstract]   [Full Text] [Related]  

  • 40. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
    Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
    J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.